BackEaston Pharmaceuticals Overview

Easton Pharmaceuticals Current Cash

Track Easton Pharmaceuticals's current cash ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$0.00

Peer average

Loading

Easton Pharmaceuticals Current Cash History

Loading

Easton Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Easton Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Easton Pharmaceuticals (EAPH) FAQ

Easton Pharmaceuticals (EAPH) currently reports a current cash of $0 as of September 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Easton Pharmaceuticals's current cash history and peer comparisons.

Easton Pharmaceuticals's current cash changed from $0 to $0 (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Easton Pharmaceuticals reported $0 in current cash as of September 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Easton Pharmaceuticals, and consider following EAPH for alerts when major investors trade the stock.

Easton Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EAPH with unrelated industries.